메뉴 건너뛰기




Volumn 142, Issue 3, 2008, Pages 492-494

Prevalence and significance of vitamin D deficiency in multiple myeloma patients

Author keywords

25 hydroxyvitamin D; Bone biomarkers; Intact parathyroid hormone; Multiple myeloma; Vitamin D deficiency

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; COLECALCIFEROL; ERGOCALCIFEROL; PARATHYROID HORMONE; VITAMIN D; ZOLEDRONIC ACID;

EID: 46949100434     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07214.x     Document Type: Letter
Times cited : (59)

References (5)
  • 1
    • 33751203850 scopus 로고    scopus 로고
    • Bone loss and fracture risk associated with cancer therapy
    • Guise, T.A. (2006) Bone loss and fracture risk associated with cancer therapy. The Oncologist, 11, 1121 1131.
    • (2006) The Oncologist , vol.11 , pp. 1121-1131
    • Guise, T.A.1
  • 4
    • 28444434713 scopus 로고    scopus 로고
    • Myeloma bone disease: Pathogenesis and treatment
    • Roodman, G.D. (2005) Myeloma bone disease: pathogenesis and treatment. Oncology (Williston Park), 19, 983 984.
    • (2005) Oncology (Williston Park) , vol.19 , pp. 983-984
    • Roodman, G.D.1
  • 5
    • 14644420230 scopus 로고    scopus 로고
    • The role of markers of bone remodeling in multiple myeloma
    • Terpos, E., Politou, M. Rahemtulla, A. (2005) The role of markers of bone remodeling in multiple myeloma. Blood Reviews, 19, 125 142.
    • (2005) Blood Reviews , vol.19 , pp. 125-142
    • Terpos, E.1    Politou, M.2    Rahemtulla, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.